000504 *ST生物
已收盘 12-15 15:00:00
资讯
新帖
简况
*ST生物（000504）公司公告披露召开2025年第四次临时股东会，11月28日股价上涨0.21%
证券之星 · 11-28
*ST生物（000504）公司公告披露召开2025年第四次临时股东会，11月28日股价上涨0.21%
每周股票复盘：*ST生物（000504）完成2341.44万元债权转让
证券之星 · 11-23
每周股票复盘：*ST生物（000504）完成2341.44万元债权转让
*ST生物：慧泽医药核心业务为药物研发及临床评价服务
证券之星 · 11-20
*ST生物：慧泽医药核心业务为药物研发及临床评价服务
*ST生物：收购娄底金弘新材料切入废旧动力电池回收业务
证券之星 · 11-20
*ST生物：收购娄底金弘新材料切入废旧动力电池回收业务
*ST生物（000504）披露债权转让暨关联交易进展公告，11月20日股价下跌0.93%
证券之星 · 11-20
*ST生物（000504）披露债权转让暨关联交易进展公告，11月20日股价下跌0.93%
每周股票复盘：*ST生物（000504）拟转让2341.44万元应收账款
证券之星 · 11-16
每周股票复盘：*ST生物（000504）拟转让2341.44万元应收账款
*ST生物(000504.SZ)：拟将日常经营活动中形成的部分应收账款转让给财信资产
中金财经 · 11-14
*ST生物(000504.SZ)：拟将日常经营活动中形成的部分应收账款转让给财信资产
异动快报：*ST生物（000504）11月12日14点35分触及涨停板
证券之星 · 11-12
异动快报：*ST生物（000504）11月12日14点35分触及涨停板
异动快报：*ST生物（000504）10月31日14点41分触及涨停板
证券之星 · 10-31
异动快报：*ST生物（000504）10月31日14点41分触及涨停板
*ST生物（000504）2025年三季报简析：净利润同比增长162.21%，公司应收账款体量较大
证券之星 · 10-28
*ST生物（000504）2025年三季报简析：净利润同比增长162.21%，公司应收账款体量较大
*ST生物(000504)9月30日股东户数1.22万户，较上期减少7.93%
证券之星 · 10-26
*ST生物(000504)9月30日股东户数1.22万户，较上期减少7.93%
每周股票复盘：*ST生物（000504）诉讼终审胜诉
证券之星 · 10-12
每周股票复盘：*ST生物（000504）诉讼终审胜诉
*ST生物（000504）披露控股孙公司诉讼事项进展公告，10月10日股价下跌1.76%
证券之星 · 10-10
*ST生物（000504）披露控股孙公司诉讼事项进展公告，10月10日股价下跌1.76%
每周股票复盘：*ST生物（000504）拟收购娄底金弘新材料股权
证券之星 · 09-28
每周股票复盘：*ST生物（000504）拟收购娄底金弘新材料股权
*ST生物（000504）披露筹划收购娄底金弘新材料股权暨增资扩股事项，9月22日股价下跌1.62%
证券之星 · 09-22
*ST生物（000504）披露筹划收购娄底金弘新材料股权暨增资扩股事项，9月22日股价下跌1.62%
每周股票复盘：*ST生物（000504）筹划收购慧泽医药51%股权
证券之星 · 09-14
每周股票复盘：*ST生物（000504）筹划收购慧泽医药51%股权
股市必读：*ST生物（000504）9月9日董秘有最新回复
证券之星 · 09-10
股市必读：*ST生物（000504）9月9日董秘有最新回复
*ST生物：慧泽医药具备CRO全链条服务能力
证券之星 · 09-09
*ST生物：慧泽医药具备CRO全链条服务能力
异动快报：*ST生物（000504）9月9日10点11分触及涨停板
证券之星 · 09-09
异动快报：*ST生物（000504）9月9日10点11分触及涨停板
每周股票复盘：*ST生物（000504）拟7862万收购娄底金弘55%股权
证券之星 · 09-07
每周股票复盘：*ST生物（000504）拟7862万收购娄底金弘55%股权
暂无数据
公司概况
公司名称：
南华生物医药股份有限公司
所属行业：
科技推广和应用服务业
上市日期：
1992-12-08
主营业务：
南华生物医药股份有限公司的主营业务是细胞医疗服务。公司的主要产品是新生儿干细胞储存和成人免疫细胞储存服务。
发行价格：
1.00
{"stockData":{"symbol":"000504","market":"SZ","secType":"STK","nameCN":"*ST生物","latestPrice":8.96,"timestamp":1765782183000,"preClose":9.06,"halted":0,"volume":1967400,"delay":0,"changeRate":-0.011,"floatShares":329000000,"shares":330000000,"eps":-0.0188,"marketStatus":"已收盘","change":-0.1,"latestTime":"12-15 15:00:00","open":9,"high":9.08,"low":8.88,"amount":17658900,"amplitude":0.0221,"askPrice":8.96,"askSize":42,"bidPrice":8.95,"bidSize":493,"shortable":0,"etf":0,"ttmEps":-0.0188,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765848600000},"marketStatusCode":5,"adr":0,"adjPreClose":9.06,"symbolType":"stock","openAndCloseTimeList":[[1765762200000,1765769400000],[1765774800000,1765782000000]],"highLimit":9.51,"lowLimit":8.61,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":330023098,"isCdr":false,"pbRate":12.34,"roa":"--","roe":"2.18%","epsLYR":-0.06,"committee":-0.455626,"marketValue":2957000000,"turnoverRate":0.006,"status":1,"floatMarketCap":2949000000},"requestUrl":"/m/hq/s/000504/tweets","defaultTab":"tweets","newsList":[{"id":"2586332067","title":"*ST生物（000504）公司公告披露召开2025年第四次临时股东会，11月28日股价上涨0.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586332067","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586332067?lang=zh_cn&edition=full","pubTime":"2025-11-28 22:37","pubTimestamp":1764340667,"startTime":"0","endTime":"0","summary":"截至2025年11月28日收盘，*ST生物报收于9.35元，较前一交易日上涨0.21%，最新总市值为30.86亿元。该股当日开盘9.33元，最高9.42元，最低9.26元，成交额达1149.11万元，换手率为0.37%。近日，南华生物发布公告称，公司将于2025年12月15日召开2025年第四次临时股东会，会议由董事会召集，现场会议地点为长沙高新开发区岳麓西大道1698号麓谷科技创新创业园B1栋三层会议室。股权登记日为2025年12月9日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800040881.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0282","000504","BK0086","BK0046"],"gpt_icon":0},{"id":"2585063921","title":"每周股票复盘：*ST生物（000504）完成2341.44万元债权转让","url":"https://stock-news.laohu8.com/highlight/detail?id=2585063921","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585063921?lang=zh_cn&edition=full","pubTime":"2025-11-23 04:27","pubTimestamp":1763843230,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，*ST生物报收于9.36元，较上周的10.23元下跌8.5%。本周，*ST生物11月17日盘中最高价报10.26元。*ST生物当前最新总市值30.89亿元，在医疗服务板块市值排名47/50，在两市A股市值排名4426/5167。本周关注点公司公告汇总：南华生物全资子公司已收到2,341.44万元债权转让款，交易完成。该债权资产截至2024年12月31日经审计的账面价值为2,341.44万元，财信资产以不低于该金额的对价受让。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300001274.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0282","BK0086","BK0046","000504"],"gpt_icon":0},{"id":"2584548131","title":"*ST生物：慧泽医药核心业务为药物研发及临床评价服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2584548131","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584548131?lang=zh_cn&edition=full","pubTime":"2025-11-20 20:48","pubTimestamp":1763642934,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST生物(000504)11月20日在投资者关系平台上答复投资者关心的问题。投资者提问：请问董秘，慧泽生物有哪些创新药产品？*ST生物回复：尊敬的投资者，您好！公司筹划收购的慧泽医药为专业CRO服务公司，核心业务为药物研发及临床评价服务（85%以上收入来源）。相关业务详情请以公司在指定媒体披露的公告为准。敬请广大投资者注意投资风险。谢谢关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000035460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","BK1574","BK0042","09939","BK0282","000504","BK1161","159938","BK0086","BK0046"],"gpt_icon":0},{"id":"2584113155","title":"*ST生物：收购娄底金弘新材料切入废旧动力电池回收业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2584113155","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584113155?lang=zh_cn&edition=full","pubTime":"2025-11-20 20:48","pubTimestamp":1763642930,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST生物11月20日在投资者关系平台上答复投资者关心的问题。请详细介绍一下收购的这家公司相关业务继续未来战略方向。*ST生物回复：尊敬的投资者，您好！公司以自有资金4,862.49万元收购娄底金弘新材料有限公司43.05%股权，并同步增资3,000万元，持股比例达55%并取得控制权。本次交易旨在切入废旧动力电池回收等新能源相关业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000035447.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","159703","BK0282","BK0046","000504","BK0042"],"gpt_icon":0},{"id":"2584918735","title":"*ST生物（000504）披露债权转让暨关联交易进展公告，11月20日股价下跌0.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584918735","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584918735?lang=zh_cn&edition=full","pubTime":"2025-11-20 17:48","pubTimestamp":1763632110,"startTime":"0","endTime":"0","summary":"截至2025年11月20日收盘，*ST生物报收于9.59元，较前一交易日下跌0.93%，最新总市值为31.65亿元。该债权资产截至2024年12月31日经审计的账面价值为2,341.44万元，财信资产以不低于该金额的对价受让。截至公告日，公司全资子公司南华干细胞再生医学临床转化研究中心有限责任公司已收到财信资产支付的全部债权转让款2,341.44万元，交易已完成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000026963.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0282","000504","BK0042","BK0046"],"gpt_icon":0},{"id":"2583546356","title":"每周股票复盘：*ST生物（000504）拟转让2341.44万元应收账款","url":"https://stock-news.laohu8.com/highlight/detail?id=2583546356","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583546356?lang=zh_cn&edition=full","pubTime":"2025-11-16 04:36","pubTimestamp":1763238972,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，*ST生物报收于10.23元，较上周的9.69元上涨5.57%。本周，*ST生物11月14日盘中最高价报10.5元。本周关注点公司公告汇总：*ST生物拟转让账面价值2,341.44万元应收账款，交易对价不低于该金额。公司公告汇总南华生物第十二届董事会第五次会议于2025年11月14日召开，审议通过《关于公司债权转让暨关联交易的议案》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600001326.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0282","000504","BK0042","BK0046"],"gpt_icon":0},{"id":"2583503196","title":"*ST生物(000504.SZ)：拟将日常经营活动中形成的部分应收账款转让给财信资产","url":"https://stock-news.laohu8.com/highlight/detail?id=2583503196","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583503196?lang=zh_cn&edition=full","pubTime":"2025-11-14 20:07","pubTimestamp":1763122022,"startTime":"0","endTime":"0","summary":"格隆汇11月14日丨*ST生物公布，为盘活存量资产，加速资金回笼，优化公司财务结构，南华生物医药股份有限公司于2025年11月14日召开了第十二届独立董事2025年第四次专门会议、第十二届董事会第五次会议分别审议通过了《关于公司债权转让暨关联交易的议案》，同意公司根据实际经营和发展所需，将日常经营活动中形成的部分应收账款转让给湖南省财信资产管理有限公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251114/31797308.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["000504","BK0086","BK0046","BK0282","BK0042"],"gpt_icon":0},{"id":"2582876342","title":"异动快报：*ST生物（000504）11月12日14点35分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2582876342","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582876342?lang=zh_cn&edition=full","pubTime":"2025-11-12 14:35","pubTimestamp":1762929324,"startTime":"0","endTime":"0","summary":"证券之星11月12日盘中消息，14点35分*ST生物触及涨停板。目前价格10.0，上涨4.17%。其所属行业医疗服务目前上涨。领涨股为诚达药业。该股为干细胞，湖南国企改革，国企改革概念热股，当日干细胞概念上涨2.8%。11月12日的资金流向数据方面，主力资金净流出183.48万元，占总成交额17.33%，游资资金净流入51.83万元，占总成交额4.89%，散户资金净流入131.65万元，占总成交额12.43%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200018015.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0046","BK0282","000504","BK0086"],"gpt_icon":0},{"id":"2579434893","title":"异动快报：*ST生物（000504）10月31日14点41分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2579434893","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579434893?lang=zh_cn&edition=full","pubTime":"2025-10-31 14:45","pubTimestamp":1761893125,"startTime":"0","endTime":"0","summary":"证券之星10月31日盘中消息，14点41分*ST生物触及涨停板。目前价格9.57，上涨5.05%。其所属行业医疗服务目前上涨。领涨股为海特生物。该股为干细胞，湖南国企改革，智慧城市概念热股，当日干细胞概念上涨2.35%，湖南国企改革概念上涨1.76%，智慧城市概念上涨1.25%。10月31日的资金流向数据方面，主力资金净流入93.84万元，占总成交额7.43%，游资资金净流出77.89万元，占总成交额6.17%，散户资金净流出15.95万元，占总成交额1.26%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100026790.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000504","BK0086","BK0046","BK0282","BK0042"],"gpt_icon":0},{"id":"2578342674","title":"*ST生物（000504）2025年三季报简析：净利润同比增长162.21%，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2578342674","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578342674?lang=zh_cn&edition=full","pubTime":"2025-10-28 06:03","pubTimestamp":1761602591,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期*ST生物发布2025年三季报。截至本报告期末，公司营业总收入8343.85万元，同比下降9.72%，归母净利润523.23万元，同比上升162.21%。本报告期*ST生物公司应收账款体量较大，当期应收账款占最新年报营业总收入比达102.8%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800006324.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000504"],"gpt_icon":0},{"id":"2578636772","title":"*ST生物(000504)9月30日股东户数1.22万户，较上期减少7.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578636772","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578636772?lang=zh_cn&edition=full","pubTime":"2025-10-26 17:13","pubTimestamp":1761470031,"startTime":"0","endTime":"0","summary":"证券之星消息，近日*ST生物披露，截至2025年9月30日公司股东户数为1.22万户，较6月30日减少1050.0户，减幅为7.93%。在医疗服务行业个股中，*ST生物股东户数低于行业平均水平，截至9月30日，医疗服务行业平均股东户数为4.63万户。从股价来看，2025年6月30日至2025年9月30日，*ST生物区间跌幅为0.84%，在此期间股东户数减少1050.0户，减幅为7.93%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600009474.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","000504","BK0042","BK0282","BK0086"],"gpt_icon":0},{"id":"2574468542","title":"每周股票复盘：*ST生物（000504）诉讼终审胜诉","url":"https://stock-news.laohu8.com/highlight/detail?id=2574468542","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574468542?lang=zh_cn&edition=full","pubTime":"2025-10-12 03:09","pubTimestamp":1760209753,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，*ST生物报收于8.91元，较上周的9.45元下跌5.71%。本周，*ST生物10月9日盘中最高价报9.55元。*ST生物当前最新总市值29.41亿元，在医疗服务板块市值排名47/50，在两市A股市值排名4514/5158。本周关注点公司公告汇总：*ST生物控股孙公司诉讼案获终审判决，对方需返还合同款1,500万元。该诉讼未对公司经营造成重大影响。除已披露事项外，公司无其他应披露未披露的重大诉讼、仲裁事项。公司将继续关注进展，维护公司及股东利益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101200000810.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","000504","BK0042","BK0282","BK0086"],"gpt_icon":0},{"id":"2574617799","title":"*ST生物（000504）披露控股孙公司诉讼事项进展公告，10月10日股价下跌1.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574617799","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574617799?lang=zh_cn&edition=full","pubTime":"2025-10-10 22:43","pubTimestamp":1760107398,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，*ST生物报收于8.91元，较前一交易日下跌1.76%，最新总市值为29.41亿元。该股当日开盘9.06元，最高9.06元，最低8.85元，成交额达2510.95万元，换手率为0.86%。近日，南华生物医药股份有限公司发布关于控股孙公司诉讼事项的进展公告。2025年1月10日，公司收到一审判决书，四方公司不服提起上诉。除已披露事项外，公司无其他应披露未披露的重大诉讼、仲裁事项。公司将继续关注进展，维护公司及股东利益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101000039686.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0282","BK0086","BK0046","000504"],"gpt_icon":0},{"id":"2570894265","title":"每周股票复盘：*ST生物（000504）拟收购娄底金弘新材料股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2570894265","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570894265?lang=zh_cn&edition=full","pubTime":"2025-09-28 04:04","pubTimestamp":1759003454,"startTime":"0","endTime":"0","summary":"截至2025年9月26日收盘，*ST生物报收于9.32元，较上周的9.85元下跌5.38%。会议审议通过《关于公司筹划以现金方式收购娄底金弘新材料有限公司股权暨增资扩股的提案》，同意股份数占出席股东有效表决权股份总数的88.0752%，反对占11.9247%，弃权100股。湖南湘军麓和律师事务所就南华生物2025年第三次临时股东会出具法律意见书。会议审议并通过《关于公司筹划以现金方式收购娄底金弘新材料有限公司股权暨增资扩股的提案》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092800001030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0046","BK0282","159703","000504","BK0042"],"gpt_icon":0},{"id":"2569673588","title":"*ST生物（000504）披露筹划收购娄底金弘新材料股权暨增资扩股事项，9月22日股价下跌1.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569673588","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569673588?lang=zh_cn&edition=full","pubTime":"2025-09-22 22:51","pubTimestamp":1758552678,"startTime":"0","endTime":"0","summary":"截至2025年9月22日收盘，*ST生物报收于9.69元，较前一交易日下跌1.62%，最新总市值为31.98亿元。根据近日发布的公告，南华生物医药股份有限公司于2025年9月22日召开2025年第三次临时股东会，会议审议通过《关于公司筹划以现金方式收购娄底金弘新材料有限公司股权暨增资扩股的提案》。出席会议的股东共366人，代表股份175,062,605股，占公司有表决权股份总数的53.0456%。其中，同意该提案的股份数占出席股东有效表决权股份总数的88.0752%，反对占11.9247%，弃权100股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092200035105.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0282","000504","BK0042","159703","BK0046"],"gpt_icon":0},{"id":"2567136464","title":"每周股票复盘：*ST生物（000504）筹划收购慧泽医药51%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2567136464","media":"证券之星","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567136464?lang=zh_cn&edition=full","pubTime":"2025-09-14 05:06","pubTimestamp":1757797578,"startTime":"0","endTime":"0","summary":"截至2025年9月12日收盘，*ST生物报收于10.52元，较上周的9.68元上涨8.68%。本周，*ST生物9月10日盘中最高价报10.81元。*ST生物当前最新总市值34.09亿元，在医疗服务板块市值排名46/50，在两市A股市值排名4259/5153。本周关注点公司公告汇总：*ST生物拟现金收购慧泽医药51%股权，交易构成重大资产重组。公司将继续履行相关审批程序和信息披露义务。本次交易尚处于筹划阶段，存在不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091400001197.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK1574","159938","000504","BK1161","BK0042","BK0086","09939","BK1515","BK0282"],"gpt_icon":0},{"id":"2566610527","title":"股市必读：*ST生物（000504）9月9日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2566610527","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566610527?lang=zh_cn&edition=full","pubTime":"2025-09-10 03:06","pubTimestamp":1757444779,"startTime":"0","endTime":"0","summary":"截至2025年9月9日收盘，*ST生物报收于10.5元，上涨5.0%，换手率2.1%，成交量6.92万手，成交额7192.78万元。请具体介绍一下董秘： 尊敬的投资者，您好。截至目前，该事项仍处于筹划阶段，公司已与交易对方签署《股权收购意向协议》，协议约定 90个自然日内排他期进行尽职调查、审计、评估等工作，双方尚未签署正式股权收购协议。相关内容详见公司于2025 年 8 月 12日在巨潮资讯网披露的《关于筹划重大资产重组暨签署股权收购意向协议的提示性公告》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091000002427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","000504","BK0282","BK0046","BK0086"],"gpt_icon":0},{"id":"2566657023","title":"*ST生物：慧泽医药具备CRO全链条服务能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2566657023","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566657023?lang=zh_cn&edition=full","pubTime":"2025-09-09 11:33","pubTimestamp":1757388826,"startTime":"0","endTime":"0","summary":"请具体介绍一下*ST生物回复：尊敬的投资者，您好。截至目前，该事项仍处于筹划阶段，公司已与交易对方签署《股权收购意向协议》，协议约定 90个自然日内排他期进行尽职调查、审计、评估等工作，双方尚未签署正式股权收购协议。相关内容详见公司于2025 年 8 月 12日在巨潮资讯网披露的《关于筹划重大资产重组暨签署股权收购意向协议的提示性公告》。需特别提醒的是，本次重大资产重组事项中，最终交易能否达成尚存在不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090900015249.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK0046","09939","000504","BK1574","BK1515","159938","BK0042","BK0282","BK0086"],"gpt_icon":0},{"id":"2566759654","title":"异动快报：*ST生物（000504）9月9日10点11分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2566759654","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566759654?lang=zh_cn&edition=full","pubTime":"2025-09-09 10:15","pubTimestamp":1757384130,"startTime":"0","endTime":"0","summary":"证券之星9月9日盘中消息，10点11分*ST生物触及涨停板。目前价格10.5，上涨5.0%。其所属行业医疗服务目前下跌。领涨股为南模生物。该股为湖南国企改革，国企改革，干细胞概念热股，当日湖南国企改革概念上涨0.34%，国企改革概念上涨0.13%，干细胞概念上涨0.02%。9月8日的资金流向数据方面，主力资金净流入730.02万元，占总成交额10.51%，游资资金净流出759.21万元，占总成交额10.93%，散户资金净流入29.19万元，占总成交额0.42%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090900010880.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","000504","BK0042","BK0086","BK0282"],"gpt_icon":0},{"id":"2565548170","title":"每周股票复盘：*ST生物（000504）拟7862万收购娄底金弘55%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2565548170","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565548170?lang=zh_cn&edition=full","pubTime":"2025-09-07 03:56","pubTimestamp":1757188573,"startTime":"0","endTime":"0","summary":"截至2025年9月5日收盘，*ST生物报收于9.68元，较上周的9.56元上涨1.26%。交易信息汇总南华生物拟以自有资金4,862.49万元收购湖南金弘再生资源集团有限公司持有的娄底金弘新材料有限公司43.05%股权，并以现金增资3,000万元，其中2,615.75万元计入注册资本。交易完成后，公司将持有娄底金弘55.00%股权，实现控制并纳入合并报表范围。股本股东变化娄底金弘新材料有限公司注册资本于2025年7月增至9,848.67万元，母公司为湖南金弘再生资源集团有限公司，实际控制人为李铁祥。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090700000733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0046","BK0282","000504","BK0042"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765815134646,"stockEarnings":[{"period":"1week","weight":-0.0055},{"period":"1month","weight":-0.1012},{"period":"3month","weight":-0.1388},{"period":"6month","weight":0.0863},{"period":"1year","weight":-0.1412},{"period":"ytd","weight":0.085}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南华生物医药股份有限公司","boardCode":"AI0075","boardName":"科技推广和应用服务业","stockholders":"12189人(较上一季度减少7.93%)","perCapita":"27001股","listingDate":"1992-12-08","address":"湖南省长沙市岳麓区高新区岳麓西大道1698号麓谷科技创新创业园B1栋3楼","registeredCapital":"33002万元","survey":" 南华生物医药股份有限公司的主营业务是细胞医疗服务。公司的主要产品是新生儿干细胞储存和成人免疫细胞储存服务。","listedPrice":1},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"*ST生物(000504)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供*ST生物(000504)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"*ST生物,000504,*ST生物股票,*ST生物股票老虎,*ST生物股票老虎国际,*ST生物行情,*ST生物股票行情,*ST生物股价,*ST生物股市,*ST生物股票价格,*ST生物股票交易,*ST生物股票购买,*ST生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"*ST生物(000504)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供*ST生物(000504)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}